[go: up one dir, main page]

EA200300862A1 - Связывание эндотоксина под действием лактобактерий и бифидобактерий - Google Patents

Связывание эндотоксина под действием лактобактерий и бифидобактерий

Info

Publication number
EA200300862A1
EA200300862A1 EA200300862A EA200300862A EA200300862A1 EA 200300862 A1 EA200300862 A1 EA 200300862A1 EA 200300862 A EA200300862 A EA 200300862A EA 200300862 A EA200300862 A EA 200300862A EA 200300862 A1 EA200300862 A1 EA 200300862A1
Authority
EA
Eurasian Patent Office
Prior art keywords
bifidobacteria
lactobacteria
action
connection
endotoxin
Prior art date
Application number
EA200300862A
Other languages
English (en)
Other versions
EA006397B1 (ru
Inventor
Эдуардо Шиффрин
Гильермо Косьюбински
Original Assignee
Сосьете Де Продюи Нестле С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179863&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200300862(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Сосьете Де Продюи Нестле С.А. filed Critical Сосьете Де Продюи Нестле С.А.
Publication of EA200300862A1 publication Critical patent/EA200300862A1/ru
Publication of EA006397B1 publication Critical patent/EA006397B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Изобретение относится к применению по меньшей мере одного штамма лактобактерий и/или бифидобактерий, обладающих гидрофобными свойствами клеточной поверхности, для приготовления композиции, предназначенной для профилактики или лечения нарушений, опосредованных эндотоксином и/или ассоциированных с ним, и пищевой композиции для человека или домашних животных, приготовленной из них.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300862A 2001-02-06 2002-02-01 Связывающие эндотоксин штаммы лактобактерий и бифидобактерий, обладающие гидрофобными свойствами, и способы их применения EA006397B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200436 2001-02-06
PCT/EP2002/001163 WO2002062360A1 (en) 2001-02-06 2002-02-01 Endotoxin binding by lactic acid bacteria and bifidobacteria

Publications (2)

Publication Number Publication Date
EA200300862A1 true EA200300862A1 (ru) 2003-12-25
EA006397B1 EA006397B1 (ru) 2005-12-29

Family

ID=8179863

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300862A EA006397B1 (ru) 2001-02-06 2002-02-01 Связывающие эндотоксин штаммы лактобактерий и бифидобактерий, обладающие гидрофобными свойствами, и способы их применения

Country Status (20)

Country Link
US (2) US7550285B2 (ru)
EP (1) EP1359924B1 (ru)
JP (3) JP2004531477A (ru)
KR (1) KR100845456B1 (ru)
CN (1) CN1250232C (ru)
AT (1) ATE375164T1 (ru)
AU (1) AU2002250886B2 (ru)
BR (1) BR0207019A (ru)
CA (1) CA2436264C (ru)
DE (1) DE60222856T2 (ru)
EA (1) EA006397B1 (ru)
ES (1) ES2292744T3 (ru)
IL (1) IL157071A0 (ru)
MX (1) MXPA03007024A (ru)
NO (1) NO20033372D0 (ru)
NZ (1) NZ527493A (ru)
PL (1) PL367083A1 (ru)
PT (1) PT1359924E (ru)
WO (1) WO2002062360A1 (ru)
ZA (1) ZA200306935B (ru)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE375164T1 (de) * 2001-02-06 2007-10-15 Nestle Sa Endotoxin-bindung durch milchsäurebakterien und bifidobacteria
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
SE526711C2 (sv) 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
US20090083067A1 (en) * 2006-03-29 2009-03-26 Mary Elaine Freeland Methods and kits for selecting a health care product
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
WO2008106373A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Product containing inactivated probiotic for children or infants
KR100913406B1 (ko) * 2008-03-25 2009-08-21 광주과학기술원 Ｔｈ１－매개 면역 질환의 예방 또는 치료용 조성물
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US9259447B2 (en) 2009-07-30 2016-02-16 Dupont Nutrition Biosciences Aps Lactic acid bacteria and bifidobacteria for treating endotoxemia
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011069860A1 (en) 2009-12-08 2011-06-16 Chr. Hansen A/S Novel use for the treatment of metabolic endotoxemia
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
WO2013009182A1 (en) 2011-07-13 2013-01-17 Friesland Brands B.V. Dairy based compositions with low lps
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
CN104780932A (zh) 2012-02-29 2015-07-15 伊西康内外科公司 微生物区系的组合物及与其相关的方法
EP3052076B1 (en) * 2013-09-30 2021-03-03 ELC Management LLC Watery lotion skin care compositions and methods
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
CN104498375B (zh) * 2014-12-02 2017-05-10 江南大学 一株具有内毒素吸附特性的耶氏酵母及其吸附特性研究方法
JP6710075B2 (ja) * 2016-03-29 2020-06-17 カゴメ株式会社 Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
TWI640319B (zh) * 2017-05-12 2018-11-11 健茂生物科技股份有限公司 具有抗發炎活性之醱酵液的製備方法
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
WO2020018949A2 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
JP6888145B2 (ja) * 2020-03-23 2021-06-16 カゴメ株式会社 Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
WO2021253017A2 (en) * 2020-06-07 2021-12-16 Ramasamy Sundaram Compositions and methods for detoxifying bacterial endotoxins and hydrogen sulfide by recombinant fusion enzymes
CN116096856A (zh) 2020-08-28 2023-05-09 科·汉森有限公司 利用辛烯基琥珀酸酐淀粉-壳聚糖复合团聚体微囊化微生物培养物
US20240417674A1 (en) * 2021-02-10 2024-12-19 Wisbiom (Beijing) Biotechnology Co., Ltd. Bifidobacterium animalis subsp. lactis and use thereof
WO2025202427A1 (en) 2024-03-28 2025-10-02 Chr. Hansen A/S Microencapsulated microbial culture using protein-carbohydrate and chitosan complex coacervate polymer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US555618A (en) * 1896-03-03 Hay-loader
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
US5413785A (en) 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
JP2506314B2 (ja) * 1993-10-27 1996-06-12 全国農業協同組合連合会 家禽・豚の敗血症の予防・治療剤及び飼料
US6506389B2 (en) * 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
PT862863E (pt) * 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
JP4163276B2 (ja) * 1998-02-05 2008-10-08 独立行政法人理化学研究所 機能性組成物
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
KR20010101171A (ko) * 1998-12-11 2001-11-14 추후기재 비뇨생식기 감염의 치료 및 예방을 위한 락토바실러스의경구 투여
IL151596A0 (en) * 2000-03-24 2003-04-10 Nestle Sa Use of lactic acid bacterium for the treatment of peritonitis
ATE375164T1 (de) * 2001-02-06 2007-10-15 Nestle Sa Endotoxin-bindung durch milchsäurebakterien und bifidobacteria

Also Published As

Publication number Publication date
NO20033372L (no) 2003-07-28
CA2436264C (en) 2014-01-28
JP5973701B2 (ja) 2016-08-23
CA2436264A1 (en) 2002-08-15
WO2002062360A1 (en) 2002-08-15
IL157071A0 (en) 2004-02-08
EA006397B1 (ru) 2005-12-29
US7550285B2 (en) 2009-06-23
JP2011246483A (ja) 2011-12-08
KR20030076652A (ko) 2003-09-26
DE60222856D1 (de) 2007-11-22
EP1359924A1 (en) 2003-11-12
ATE375164T1 (de) 2007-10-15
NZ527493A (en) 2005-06-24
BR0207019A (pt) 2004-02-25
CN1250232C (zh) 2006-04-12
KR100845456B1 (ko) 2008-07-10
US20040115178A1 (en) 2004-06-17
US7964384B2 (en) 2011-06-21
CN1501805A (zh) 2004-06-02
JP2014062104A (ja) 2014-04-10
ZA200306935B (en) 2004-12-06
DE60222856T2 (de) 2008-07-24
MXPA03007024A (es) 2003-11-18
JP2004531477A (ja) 2004-10-14
EP1359924B1 (en) 2007-10-10
ES2292744T3 (es) 2008-03-16
PL367083A1 (en) 2005-02-21
NO20033372D0 (no) 2003-07-28
AU2002250886B2 (en) 2007-08-02
US20100136662A1 (en) 2010-06-03
HK1066174A1 (en) 2005-03-18
PT1359924E (pt) 2007-12-07

Similar Documents

Publication Publication Date Title
EA200300862A1 (ru) Связывание эндотоксина под действием лактобактерий и бифидобактерий
BR0211888A (pt) Materiais e métodos para promoção de reparo de tecido nervoso
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
EP2204176A3 (en) Nutritional Composition
BR0116349A (pt) Compostos probióticos derivados da cepa ke01 de lactobacillus casei
WO2005110445A3 (en) Methods and compositions for the dietary management of autoimmune disorders
EP2305269A3 (en) Immunemodulating oligosaccharides
HK1049115A1 (zh) 治療過敏性失調的成分和方法
IL147271A0 (en) Compounds that bind her2
EP1800691A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
EP2316466A3 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
IL141325A0 (en) Tan-1057 derivatives
WO2006082328A3 (fr) Compositions comprenant des micro-organismes deshydrates, leurs procedes de preparation, et leurs utilisations
BRPI0407176B8 (pt) composições compreendendo uma ou mais cepas de bifidobacterium e seus usos
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
ATE458004T1 (de) Osteoprotegerin in milch
WO2002060382A3 (en) Novel compounds and uses thereof
WO2003026693A3 (en) Inhibitors of costimulation by 0x40 and their use against infectious diseases
WO2007058934A3 (en) Methods and compositions for treating basement membrane disorders
WO2003053959A8 (de) Heterocyclylaminocarbo nyluracile

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU